TrialESC heart failure2021

Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data.

Nicholas J Viney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.